The University of Chicago Header Logo

Connection

Eric Pamer to Male

Back to Details
This is a "connection" page, showing publications Eric Pamer has written about Male.
Eric Pamer
Connection Strength
0.435
Male
  1. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med. 2016 08 15; 194(4):450-63.
    View in: PubMed
    Score: 0.030
  2. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014 Aug 14; 124(7):1174-82.
    View in: PubMed
    Score: 0.025
  3. Cuffed and exposed--perp-walking bradyrhizobium. N Engl J Med. 2013 Aug 08; 369(6):572-4.
    View in: PubMed
    Score: 0.024
  4. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med. 2012 Jul 30; 209(8):1445-56.
    View in: PubMed
    Score: 0.022
  5. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012 Oct; 55(7):905-14.
    View in: PubMed
    Score: 0.022
  6. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis. 2010 Feb 15; 201(4):534-43.
    View in: PubMed
    Score: 0.019
  7. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021 03 18; 137(11):1527-1537.
    View in: PubMed
    Score: 0.010
  8. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000 Oct 15; 96(8):2814-21.
    View in: PubMed
    Score: 0.010
  9. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 02 27; 382(9):822-834.
    View in: PubMed
    Score: 0.009
  10. Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):81-89.
    View in: PubMed
    Score: 0.009
  11. Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunol Res. 2020 02; 8(2):192-202.
    View in: PubMed
    Score: 0.009
  12. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019 11 29; 366(6469):1143-1149.
    View in: PubMed
    Score: 0.009
  13. Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients. Transpl Infect Dis. 2019 Dec; 21(6):e13167.
    View in: PubMed
    Score: 0.009
  14. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. Transpl Infect Dis. 2019 Dec; 21(6):e13180.
    View in: PubMed
    Score: 0.009
  15. Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv. 2019 07 09; 3(13):2040-2044.
    View in: PubMed
    Score: 0.009
  16. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019 01 07; 216(1):84-98.
    View in: PubMed
    Score: 0.009
  17. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant. 2019 02; 19(2):488-500.
    View in: PubMed
    Score: 0.008
  18. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018 06 28; 131(26):2978-2986.
    View in: PubMed
    Score: 0.008
  19. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018 04 10; 2(7):745-753.
    View in: PubMed
    Score: 0.008
  20. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Cancer Causes Control. 2017 Sep; 28(9):959-969.
    View in: PubMed
    Score: 0.008
  21. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2017 04 01; 215(7):1117-1123.
    View in: PubMed
    Score: 0.008
  22. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol. 2017 May 20; 35(15):1650-1659.
    View in: PubMed
    Score: 0.008
  23. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 May; 23(5):845-852.
    View in: PubMed
    Score: 0.008
  24. Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden. Cancer Prev Res (Phila). 2016 Sep; 9(9):721-31.
    View in: PubMed
    Score: 0.007
  25. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520.
    View in: PubMed
    Score: 0.007
  26. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016 Feb 02; 7:10391.
    View in: PubMed
    Score: 0.007
  27. IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy? Science. 2015 Nov 27; 350(6264):1031-2.
    View in: PubMed
    Score: 0.007
  28. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):8-15.
    View in: PubMed
    Score: 0.007
  29. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1373-83.
    View in: PubMed
    Score: 0.007
  30. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015; 10(3):e0122399.
    View in: PubMed
    Score: 0.007
  31. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015 Jan; 67(1):128-39.
    View in: PubMed
    Score: 0.007
  32. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014 Oct 15; 98(7):697-705.
    View in: PubMed
    Score: 0.006
  33. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature. 2014 Oct 30; 514(7524):638-41.
    View in: PubMed
    Score: 0.006
  34. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014; 9(3):e90158.
    View in: PubMed
    Score: 0.006
  35. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013 Nov 05; 2:e01202.
    View in: PubMed
    Score: 0.006
  36. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012 Oct; 64(10):3083-94.
    View in: PubMed
    Score: 0.006
  37. Dynamic imaging of the effector immune response to listeria infection in vivo. PLoS Pathog. 2011 Mar; 7(3):e1001326.
    View in: PubMed
    Score: 0.005
  38. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1576-81.
    View in: PubMed
    Score: 0.005
  39. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010 Apr; 60(4):257-63.
    View in: PubMed
    Score: 0.005
  40. Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study. Biol Blood Marrow Transplant. 2008 Dec; 14(12):1429-33.
    View in: PubMed
    Score: 0.004
  41. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect. 2008 Dec; 57(6):464-71.
    View in: PubMed
    Score: 0.004
  42. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis. 2008 Jun; 10(3):162-7.
    View in: PubMed
    Score: 0.004
  43. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis. 2007 Jun; 9(2):108-13.
    View in: PubMed
    Score: 0.004
  44. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2007 Dec; 9(4):286-94.
    View in: PubMed
    Score: 0.004
  45. Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model. Blood. 2006 Mar 01; 107(5):2045-51.
    View in: PubMed
    Score: 0.003
  46. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005 Mar; 7(1):11-7.
    View in: PubMed
    Score: 0.003
  47. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004 Dec 01; 39(11):1625-32.
    View in: PubMed
    Score: 0.003
  48. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004 Jan 15; 172(2):1287-94.
    View in: PubMed
    Score: 0.003
  49. Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood. 2003 Jun 01; 101(11):4290-7.
    View in: PubMed
    Score: 0.003
  50. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis. 2002 Aug 01; 35(3):E35-6.
    View in: PubMed
    Score: 0.003
  51. A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect Immun. 1996 May; 64(5):1685-93.
    View in: PubMed
    Score: 0.002
  52. Peptide presentation by the MHC class Ib molecule, H2-M3. Int Immunol. 1994 Dec; 6(12):1917-26.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.